Annual summary of publications
Publications (original articles or review articles) published in 2011 from OUS - Department of Infectious Diseases
20 publications found
Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza
J Infect, 63 (4), 308-16
DOI 10.1016/j.jinf.2011.07.004, PubMed 21781987
Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
BMC Infect Dis, 11, 75
DOI 10.1186/1471-2334-11-75, PubMed 21435254
Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells?--Implications for cancer immunotherapy by adoptive T cell transfer
Scand J Immunol, 73 (6), 527-30
DOI 10.1111/j.1365-3083.2011.02558.x, PubMed 21388431
Antibiotic prescribing in nursing homes in an area with low prevalence of antibiotic resistance: compliance with national guidelines
Scand J Prim Health Care, 30 (1), 10-5
DOI 10.3109/02813432.2011.629156, PubMed 22188479
Increased antibiotic use in Norwegian hospitals despite a low antibiotic resistance rate
J Antimicrob Chemother, 66 (11), 2643-6
DOI 10.1093/jac/dkr361, PubMed 21903657
Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals
BMC Med Res Methodol, 11, 166
DOI 10.1186/1471-2288-11-166, PubMed 22166018
Two Norwegian patients with melioidosis presenting with bacteraemia and splenic and prostatic abscesses
J Travel Med, 18 (6), 418-21
DOI 10.1111/j.1708-8305.2011.00550.x, PubMed 22017720
Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania
BMC Infect Dis, 11, 190
DOI 10.1186/1471-2334-11-190, PubMed 21745396
HIV target cells in Schistosoma haematobium-infected female genital mucosa
Am J Trop Med Hyg, 85 (6), 1060-4
DOI 10.4269/ajtmh.2011.11-0135, PubMed 22144444
Increased vascularity in cervicovaginal mucosa with Schistosoma haematobium infection
PLoS Negl Trop Dis, 5 (6), e1170
DOI 10.1371/journal.pntd.0001170, PubMed 21666790
p24 antigen detection on dried blood spots is a feasible and reliable test for infant HIV infection in rural Tanzania
Int J STD AIDS, 22 (12), 719-21
DOI 10.1258/ijsa.2009.009382, PubMed 22174052
Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infection
APMIS, 120 (3), 204-9
DOI 10.1111/j.1600-0463.2011.02843.x, PubMed 22339677
Travel-related imported infections in Europe, EuroTravNet 2009
Clin Microbiol Infect, 18 (5), 468-74
DOI 10.1111/j.1469-0691.2011.03596.x, PubMed 21848975
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
J Virol, 85 (13), 6557-66
DOI 10.1128/JVI.00073-11, PubMed 21490090
Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy
AAPS J, 13 (4), 598-605
DOI 10.1208/s12248-011-9299-0, PubMed 21913053
Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients
J Pharmacokinet Pharmacodyn, 38 (6), 727-42
DOI 10.1007/s10928-011-9217-1, PubMed 21964996
The Norwegian experience with penicillin G plus an aminoglycoside as initial empiric therapy in febrile neutropenia; a review
Acta Oncol, 51 (4), 433-40
DOI 10.3109/0284186X.2011.633931, PubMed 22175253
The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily
Scand J Immunol, 74 (6), 632-9
DOI 10.1111/j.1365-3083.2011.02618.x, PubMed 21883353
High mobility group box protein-1 in HIV-1 infection
Curr HIV Res, 9 (1), 6-10
DOI 10.2174/157016211794582632, PubMed 21198433
The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007
AIDS, 25 (8), 1083-91
DOI 10.1097/QAD.0b013e3283471cce, PubMed 21537114